Dyne Therapeutics, Inc. · NASDAQ:DYN
Kerr Douglas sold 1,564 Dyne Therapeutics, Inc. shares (Form 4)
Traded May 13, 2026 · Filed May 14, 2026
On May 13, 2026, Kerr Douglas (Chief Medical Officer) sold 1,564 Dyne Therapeutics, Inc. shares at US$18.36 for US$28,715 under a trading plan, leaving 170,042 shares. Filed May 14, 2026 (Form 4).
- Sold
- 1,564 shares
- Price
- US$18.36
- Value
- US$28,715
- Holding after
- 170,042 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 13, 2026 | Common Stock | Sale | 1,564 | US$18.36 | 170,042 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Kerr Douglas
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Kerr Douglas · Aug 17, 2026
- Form 4 · Kerr Douglas · Jun 17, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026
- Form 4 · Cox John · Aug 17, 2026